Prostate Cancer Trial, Recruiting (NCT07398690)

Prostate Cancer Trial, Recruiting NCT07398690 Sponsor: In Gab Jeong, MD Condition: Prostate Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT07398690 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Prostate Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

People who are male and aged 20 years or older
People whose PSA blood test result is between 3.0 and 20.0 ng/mL, or who have had an abnormal prostate examination by a doctor (confirm with trial site)
People who have never had a prostate biopsy before
People whose cancer or suspected condition has not spread beyond or significantly outside the prostate gland, as assessed by a doctor
People who are able to read and sign a consent form agreeing to take part

Who may not be able to join:

People who have previously had a prostate biopsy or any treatment for prostate cancer
People who have taken certain medications used to treat prostate or hair conditions (called 5-alpha reductase inhibitors) in the past 6 months
People who have had a prostate infection or urinary tract infection in the past 3 months
People for whom an MRI scan is not safe or suitable (for example, those with certain metal implants)
People for whom a prostate biopsy procedure would not be safe or suitable

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 8 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 82-2-3010-5892

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT07398690

Sponsor: In Gab Jeong, MD

Phase: Not Applicable

Status: Recruiting

Condition: Prostate Cancer

Trial contact: 82-2-3010-5892

More information: https://clinicaltrials.gov/study/NCT07398690

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

People who are male and aged 20 years or older
People whose PSA blood test result is between 3.0 and 20.0 ng/mL, or who have had an abnormal prostate examination by a doctor (confirm with trial site)
People who have never had a prostate biopsy before
People whose cancer or suspected condition has not spread beyond or significantly outside the prostate gland, as assessed by a doctor
People who are able to read and sign a consent form agreeing to take part

Who may not be able to join:

People who have previously had a prostate biopsy or any treatment for prostate cancer
People who have taken certain medications used to treat prostate or hair conditions (called 5-alpha reductase inhibitors) in the past 6 months
People who have had a prostate infection or urinary tract infection in the past 3 months
People for whom an MRI scan is not safe or suitable (for example, those with certain metal implants)
People for whom a prostate biopsy procedure would not be safe or suitable

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 8 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

In Gab Jeong, MD

Registry

ClinicalTrials.gov

Start date

9 March 2026

Est. completion

31 December 2027

Where this trial is recruiting

🇰🇷 South Korea

Primary endpoints

Detection of clinically significant prostate cancer

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 8 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov